Project Scope |
Best Practices in Data Standards Implementation Governance will cover the following areas:
|
Project Leads | ||
Ellen Asam, Merck | ellen_asam@merck.com | |
Sandy VanPelt Nguyen, Pfizer | ||
Nicola Newton, PHUSE Project Assistant | )paula@phuse | |
Objectives & Deliverables | Timelines | |
Q22021 Q32021 Q42021 Q22021 |
| Q22021||||||
Still in the process of drafting survey questions. We plan to use CSS sessions to finalise the questions and distribute shortly after, so distribution may fall into October, slightly past planned Q3 delivery. | ||||||
Project Members | Organisation | |||||
Aimee Basile | Surface Oncology | |||||
Brook (Amanda) Hinkson | Merck | |||||
Carlo Radovsky | Immanant | |||||
Cathy Yang | Roche | |||||
Gayathri Mahadevan | Cytel | |||||
Jennifer Jarvis | Eli Lilly | |||||
Junying Zhang | Gilead | |||||
Ligia Kilinski Cevasco | Jazz Pharmaceuticals | |||||
Parisa Osivand Pour | Industry | |||||
Patrick Genyn | Janssen Research and Development | |||||
Ranvir Singh | Covance | |||||
Rie Ichihashi | Sanofi | |||||
Sathesh Avvaru | PPD | |||||
Tingting Tian | Regeneron | |||||
Titania Dumas-Roberson | Unither Pharmaceuticals | |||||
Todd Bazin | Biogen | |||||
Torsten Petsching | Boehringer Ingelheim | |||||
Rong Ye | EBSI
| |||||
|
Objectives & Deliverables | Timelines |
White Paper Published | Q4 2024 |
Publish White Paper | Q3 2024 |
Potentially make updates to White Paper following PHUSE Steering Committee and Public Review feedback | Q3 2023 |